1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    

































































































































































    Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleADULT BRAIN

  
      
Open Access

  
      
Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET
  
    	
G.C. Chiang, X. Mao, G. Kang, E. Chang, S. Pandya, S. Vallabhajosula, R. Isaacson, L.D. Ravdin, for the Alzheimer's Disease Neuroimaging Initiative and D.C. Shungu

  
    	
American Journal of Neuroradiology June 2017,  38 (6) 1130-1137; DOI: https://doi.org/10.3174/ajnr.A5143 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    Alzheimer's Association. 2016 Alzheimer's disease facts and figures. http://www.alz.org/facts/. Accessed May 29, 2016. 
  2. 2.↵
    1. 

    2. Mangialasche  F, 
    3. Solomon  A, 
    4. Winblad  B, et al
    . Alzheimer's disease: clinical trials and drug development. Lancet Neurol 2010;9:702–16 doi:10.1016/S1474-4422(10)70119-8 pmid:20610346
    CrossRefPubMedWeb of Science
  3. 3.↵
    1. 

    2. Apelt  J, 
    3. Bigl  M, 
    4. Wunderlich  P, et al
    . Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. Int J Dev Neurosci 2004;22:475–84 doi:10.1016/j.ijdevneu.2004.07.006 pmid:15465277
    CrossRefPubMedWeb of Science
  4. 4.↵
    1. 

    2. Nunomura  A, 
    3. Perry  G, 
    4. Aliev  G, et al
    . Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759–67 doi:10.1093/jnen/60.8.759 pmid:11487050
    Abstract/FREE Full Text
  5. 5.↵
    1. 

    2. Praticò  D, 
    3. Uryu  K, 
    4. Leight  S, et al
    . Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001;21:4183–87 pmid:11404403
    Abstract/FREE Full Text
  6. 6.↵
    1. 

    2. Komatsu  H, 
    3. Liu  L, 
    4. Murray  IV, et al
    . A mechanistic link between oxidative stress and membrane mediated amyloidogenesis revealed by infrared spectroscopy. Biochim Biophys Acta 2007;1768:1913–22 doi:10.1016/j.bbamem.2007.05.026 pmid:17632073
    CrossRefPubMed
  7. 7.↵
    1. 

    2. Nunomura  A, 
    3. Castellani  RJ, 
    4. Zhu  X, et al
    . Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 2006;65:631–41 doi:10.1097/01.jnen.0000228136.58062.bf pmid:16825950
    Abstract/FREE Full Text
  8. 8.↵
    1. 

    2. Bonda  DJ, 
    3. Wang  X, 
    4. Lee  HG, et al
    . Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass. Neurosci Bull 2014;30:243–52 doi:10.1007/s12264-013-1424-x pmid:24733654
    CrossRefPubMed
  9. 9.↵
    1. 

    2. Pocernich  CB, 
    3. Butterfield  DA
    . Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochim Biophys Acta 2012;1822:625–30 doi:10.1016/j.bbadis.2011.10.003 pmid:22015471
    CrossRefPubMed
  10. 10.↵
    1. 

    2. Resende  R, 
    3. Moreira  PI, 
    4. Proença  T, et al
    . Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008;44:2051–57 doi:10.1016/j.freeradbiomed.2008.03.012 pmid:18423383
    CrossRefPubMedWeb of Science
  11. 11.↵
    1. 

    2. Zhang  C, 
    3. Rodriguez  C, 
    4. Spaulding  J, et al
    . Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease. J Alzheimers Dis 2012;28:655–66 doi:10.3233/JAD-2011-111244 pmid:22045490
    CrossRefPubMed
  12. 12.↵
    1. 

    2. Hensley  K, 
    3. Carney  JM, 
    4. Mattson  MP, et al
    . A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A 1994;91:3270–74 doi:10.1073/pnas.91.8.3270 pmid:8159737
    Abstract/FREE Full Text
  13. 13.↵
    1. 

    2. Smith  MA, 
    3. Casadesus  G, 
    4. Joseph  JA, et al
    . Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 2002;33:1194–99 doi:10.1016/S0891-5849(02)01021-3 pmid:12398927
    CrossRefPubMedWeb of Science
  14. 14.↵
    1. 

    2. Rowe  CC, 
    3. Villemagne  VL
    . Brain amyloid imaging. J Nucl Med 2011;52:1733–40 doi:10.2967/jnumed.110.076315 pmid:21917849
    Abstract/FREE Full Text
  15. 15.↵
    1. 

    2. Barnes  DE, 
    3. Yaffe  K
    . The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011;10:819–28 doi:10.1016/S1474-4422(11)70072-2 pmid:21775213
    CrossRefPubMedWeb of Science
  16. 16.↵
    1. 

    2. Sato  N, 
    3. Morishita  R
    . The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease. Front Aging Neurosci 2015;7:199 doi:10.3389/fnagi.2015.00199 pmid:26557086
    CrossRefPubMed
  17. 17.↵
    1. 

    2. Mosconi  L, 
    3. Rinne  JO, 
    4. Tsui  WH, et al
    . Increased fibrillar amyloid-β burden in normal individuals with a family history of late-onset Alzheimer's. Proc Natl Acad Sci U S A 2010;107:5949–54 doi:10.1073/pnas.0914141107 pmid:20231448
    Abstract/FREE Full Text
  18. 18.↵
    1. 

    2. Lasa  L, 
    3. Ayuso-Mateos  JL, 
    4. Vázquez-Barquero  JL, et al
    . The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis. J Affect Disord 2000;57:261–65 doi:10.1016/S0165-0327(99)00088-9 pmid:10708841
    CrossRefPubMedWeb of Science
  19. 19.↵
    1. 

    2. Beck  AT, 
    3. Epstein  N, 
    4. Brown  G, et al
    . An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893–97 doi:10.1037/0022-006X.56.6.893 pmid:3204199
    CrossRefPubMedWeb of Science
  20. 20.↵
    1. 

    2. Randolph  C, 
    3. Tierney  MC, 
    4. Mohr  E, et al
    . The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998;20:310–19 doi:10.1076/jcen.20.3.310.823 pmid:9845158
    CrossRefPubMedWeb of Science
  21. 21.↵
    1. 

    2. Karantzoulis  S, 
    3. Novitski  J, 
    4. Gold  M, et al
    . The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease. Arch Clin Neuropsychol 2013;28:837–44 doi:10.1093/arclin/act057 pmid:23867976
    Abstract/FREE Full Text
  22. 22.↵
    1. 

    2. Saykin  AJ, 
    3. Shen  L, 
    4. Foroud  TM, et al
    ; Alzheimer's Disease Neuroimaging Initiative. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans. Alzheimers Dement 2010;6:265–73 doi:10.1016/j.jalz.2010.03.013 pmid:20451875
    CrossRefPubMedWeb of Science
  23. 23.↵
    1. 

    2. Herholz  K, 
    3. Salmon  E, 
    4. Perani  D, et al
    . Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17:302–16 doi:10.1006/nimg.2002.1208 pmid:12482085
    CrossRefPubMedWeb of Science
  24. 24.↵
    1. 

    2. Vogt  BA, 
    3. Vogt  LJ, 
    4. Vrana  KE, et al
    . Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease. Exp Neurol 1998;153:8–22 doi:10.1006/exnr.1998.6852 pmid:9743563
    CrossRefPubMedWeb of Science
  25. 25.↵
    1. 

    2. Murray  ME, 
    3. Przybelski  SA, 
    4. Lesnick  TG, et al
    . Early Alzheimer's disease neuropathology detected by proton MR spectroscopy. J Neurosci 2014;34:16247–55 doi:10.1523/JNEUROSCI.2027-14.2014 pmid:25471565
    Abstract/FREE Full Text
  26. 26.↵
    1. 

    2. Kantarci  K
    . 1H magnetic resonance spectroscopy in dementia. Br J Radiol 2007;80:S146–52 doi:10.1259/bjr/60346217 pmid:18445744
    Abstract/FREE Full Text
  27. 27.↵
    1. 

    2. Shungu  DC, 
    3. Weiduschat  N, 
    4. Murrough  JW, et al
    . Increased ventricular lactate in chronic fatigue syndrome, III: relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed 2012;25:1073–87 doi:10.1002/nbm.2772 pmid:22281935
    CrossRefPubMedWeb of Science
  28. 28.↵
    1. 

    2. Weiduschat  N, 
    3. Mao  X, 
    4. Hupf  J, et al
    . Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique. Neurosci Lett 2014;570:102–07 doi:10.1016/j.neulet.2014.04.020 pmid:24769125
    CrossRefPubMed
  29. 29.↵
    1. 

    2. Geramita  M, 
    3. van der Veen  JW, 
    4. Barnett  AS, et al
    . Reproducibility of prefrontal γ-aminobutyric acid measurements with J-edited spectroscopy. NMR Biomed 2011;24:1089–98 doi:10.1002/nbm.1662 pmid:21290458
    CrossRefPubMedWeb of Science
  30. 30.↵
    1. 

    2. Mullins  PG, 
    3. McGonigle  DJ, 
    4. O'Gorman  RL, et al
    . Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage 2014;86:43–52 doi:10.1016/j.neuroimage.2012.12.004 pmid:23246994
    CrossRefPubMedWeb of Science
  31. 31.↵
    1. 

    2. An  L, 
    3. Zhang  Y, 
    4. Thomasson  DM, et al
    . Measurement of glutathione in normal volunteers and stroke patients at 3T using J-difference spectroscopy with minimized subtraction errors. J Magn Reson Imaging 2009;30:263–70 doi:10.1002/jmri.21832 pmid:19629994
    CrossRefPubMed
  32. 32.↵
    1. 

    2. Nepravishta  R, 
    3. Sabelli  R, 
    4. Iorio  E, et al
    . Oxidative species and S-glutathionyl conjugates in the apoptosis induction by allyl thiosulfate. FEBS J 2012;279:154–67 doi:10.1111/j.1742-4658.2011.08407.x pmid:22035263
    CrossRefPubMed
  33. 33.↵
    1. 

    2. Shungu  DC, 
    3. Mao  X, 
    4. Gonzales  R, et al
    . Brain γ-aminobutyric acid (GABA) detection in vivo with the J-editing (1) H MRS technique: a comprehensive methodological evaluation of sensitivity enhancement, macromolecule contamination and test-retest reliability. NMR Biomed 2016;29:932–42 doi:10.1002/nbm.3539 pmid:27173449
    CrossRefPubMed
  34. 34.↵
    1. 

    2. Smith  SM
    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55 doi:10.1002/hbm.10062 pmid:12391568
    CrossRefPubMedWeb of Science
  35. 35.↵
    1. 

    2. Tzourio-Mazoyer  N, 
    3. Landeau  B, 
    4. Papathanassiou  D, et al
    . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89 doi:10.1006/nimg.2001.0978 pmid:11771995
    CrossRefPubMedWeb of Science
  36. 36.↵
    1. 

    2. Mormino  EC, 
    3. Kluth  JT, 
    4. Madison  CM, et al
    ; Alzheimer's Disease Neuroimaging Initiative. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009;132(pt 5):1310–23 doi:10.1093/brain/awn320 pmid:19042931
    Abstract/FREE Full Text
  37. 37.↵
    1. 

    2. Jagust  WJ, 
    3. Landau  SM, 
    4. Shaw  LM, et al
    ; Alzheimer's Disease Neuroimaging Initiative. Relationships between biomarkers in aging and dementia. Neurology 2009;73:1193–99 doi:10.1212/WNL.0b013e3181bc010c pmid:19822868
    Abstract/FREE Full Text
  38. 38.↵
    1. 

    2. Landau  SM, 
    3. Breault  C, 
    4. Joshi  AD, et al
    ; Alzheimer's Disease Neuroimaging Initiative. Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med 2013;54:70–77 doi:10.2967/jnumed.112.109009 pmid:23166389
    Abstract/FREE Full Text
  39. 39.↵
    1. 

    2. Jagust  WJ, 
    3. Landau  SM, 
    4. Koeppe  RA, et al
    . The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimers Dement 2015;11:757–71 doi:10.1016/j.jalz.2015.05.001 pmid:26194311
    CrossRefPubMed
  40. 40.↵
    1. 

    2. Schmechel  DE, 
    3. Saunders  AM, 
    4. Strittmatter  WJ, et al
    . Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:9649–53 doi:10.1073/pnas.90.20.9649 pmid:8415756
    Abstract/FREE Full Text
  41. 41.↵
    1. 

    2. Reiman  EM, 
    3. Chen  K, 
    4. Liu  X, et al
    . Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 2009;106:6820–25 doi:10.1073/pnas.0900345106 pmid:19346482
    Abstract/FREE Full Text
  42. 42.↵
    1. 

    2. Bu  G
    . Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009;10:333–44 doi:10.1038/nrn2620 pmid:19339974
    CrossRefPubMedWeb of Science
  43. 43.↵
    1. 

    2. Small  GW, 
    3. Siddarth  P, 
    4. Burggren  AC, et al
    . Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry 2009;66:81–87 doi:10.1001/archgenpsychiatry.2008.516 pmid:19124691
    CrossRefPubMedWeb of Science
  44. 44.↵
    1. 

    2. Vittinghoff  E, 
    3. Shiboski  S, 
    4. Glidden  D, et al
    . Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York: Springer-Science and Business Media; 2005;62:138–39
  45. 45.↵
    1. 

    2. Cohen  J
    . A power primer. Psychol Bull 1992;112:155–59 pmid:19565683
    CrossRefPubMedWeb of Science
  46. 46.↵
    How can I compute effect size in Stata for regression? UCLA: Institute for Digital Research and Education. http://www.ats.ucla.edu/stat/stata/faq/regeffectsize.htm. Accessed December 15, 2016. 
  47. 47.↵
    1. 

    2. Cohen  JW
    . Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988
  48. 48.↵
    1. 

    2. Corder  EH, 
    3. Saunders  AM, 
    4. Strittmatter  WJ, et al
    . Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921–23 doi:10.1126/science.8346443 pmid:8346443
    Abstract/FREE Full Text
  49. 49.↵
    1. 

    2. Seshadri  S, 
    3. Drachman  DA, 
    4. Lippa  CF
    . Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease: what physicians know, and what they should know. Arch Neurol 1995;52:1074–79 doi:10.1001/archneur.1995.00540350068018 pmid:7487559
    CrossRefPubMedWeb of Science
  50. 50.↵
    1. 

    2. Mandal  PK, 
    3. Saharan  S, 
    4. Tripathi  M, et al
    . Brain glutathione levels–a novel biomarker for mild cognitive impairment and Alzheimer's disease. Biol Psychiatry 2015;78:702–10 doi:10.1016/j.biopsych.2015.04.005 pmid:26003861
    CrossRefPubMed
  51. 51.↵
    1. 

    2. Gu  M, 
    3. Owen  AD, 
    4. Toffa  SE, et al
    . Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci 1998;158:24–29 doi:10.1016/S0022-510X(98)00095-1 pmid:9667773
    CrossRefPubMed
  52. 52.↵
    1. 

    2. Jain  A, 
    3. Mårtensson  J, 
    4. Stole  E, et al
    . Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci U S A 1991;88:1913–17 doi:10.1073/pnas.88.5.1913 pmid:2000395
    Abstract/FREE Full Text
  53. 53.↵
    1. 

    2. Venkateshappa  C, 
    3. Harish  G, 
    4. Mahadevan  A, et al
    . Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease. Neurochem Res 2012;37:1601–14 doi:10.1007/s11064-012-0755-8 pmid:22461064
    CrossRefPubMed
  54. 54.↵
    1. 

    2. Gibson  GE, 
    3. Starkov  A, 
    4. Blass  JP, et al
    . Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 2010;1802:122–34 doi:10.1016/j.bbadis.2009.08.010 pmid:19715758
    CrossRefPubMedWeb of Science
  55. 55.↵
    1. 

    2. Lin  MT, 
    3. Beal  MF
    . Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443:787–95 doi:10.1038/nature05292 pmid:17051205
    CrossRefPubMedWeb of Science
  56. 56.↵
    1. 

    2. Duffy  SL, 
    3. Lagopoulos  J, 
    4. Hickie  IB, et al
    . Glutathione relates to neuropsychological functioning in mild cognitive impairment. Alzheimers Dement 2014;10:67–75 doi:10.1016/j.jalz.2013.01.005 pmid:23688577
    CrossRefPubMedWeb of Science
  57. 57.↵
    1. 

    2. Lezak  MD, 
    3. Howieson  D, 
    4. Loring  D
    . Neuropsychological Assessment, 4th ed. Oxford: Oxford University Press; 2004:207–15
  58. 58.↵
    1. 

    2. Blacker  D, 
    3. Lee  H, 
    4. Muzikansky  A, et al
    . Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol 2007;64:862–71 doi:10.1001/archneur.64.6.862 pmid:17562935
    CrossRefPubMedWeb of Science
  59. 59.↵
    1. 

    2. Wonisch  W, 
    3. Falk  A, 
    4. Sundl  I, et al
    . Oxidative stress increases continuously with BMI and age with unfavourable profiles in males. Aging Male 2012;15:159–65 doi:10.3109/13685538.2012.669436 pmid:22468695
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET
  
    	
G.C. Chiang, X. Mao, G. Kang, E. Chang, S. Pandya, S. Vallabhajosula, R. Isaacson, L.D. Ravdin, for the Alzheimer's Disease Neuroimaging Initiative, D.C. Shungu

  
    	
 American Journal of Neuroradiology Jun 2017, 38 (6) 1130-1137; DOI: 10.3174/ajnr.A5143 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement